Fridays vs Remedy Meds

Remedy Meds has an open FDA warning letter dated September 9, 2025. Fridays has none. On compounded semaglutide injection, Fridays costs $600 less a year at standing rates: $249 a month against $299 a month at Remedy Meds. It is one of two products the two sell at comparable terms.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Fridays / Remedy Meds

Fridays logo

Fridays

5.8/10

Remedy Meds logo

Remedy Meds

5.6/10

FDA warning letters
None on record
Pharmacy
None named in our record
Lowest standing price
$249/moCompounded semaglutide injection
$299/moCompounded semaglutide injection
States
No state list published
49 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026

Neither Fridays nor Remedy Meds pays us. Links to them earn nothing. Scores: Fridays 5.8, Remedy Meds 5.6. How we are paid

What the record shows

  1. 01

    Remedy Meds has an open FDA warning letter dated September 9, 2025. Fridays has none.

  2. 02

    Fridays names four pharmacies. Remedy Meds names no compounding pharmacy in our record.

  3. 03

    On compounded semaglutide injection, Fridays costs $600 less a year at standing rates: $249 a month against $299 a month at Remedy Meds. It is one of two products the two sell at comparable terms.

  4. 04

    Only Fridays lists a price for brand-name semaglutide pen and brand-name tirzepatide pen.

  5. 05

    Remedy Meds lists 49 states. Fridays publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Fridays

Remedy Meds

Compounded semaglutide injection

$249/moLower

$2,988 a year

$299/mo

$3,588 a year

Compounded tirzepatide injection

$359/moLower

$4,308 a year

$399/mo

$4,788 a year

Brand-name semaglutide pen

$1,498/mo

$17,976 a year

Not sold or not priced
Brand-name tirzepatide pen

$1,828/mo

$21,936 a year

Not sold or not priced
Price includes
Medication, clinician visits, coaching
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the monthly plan; 3, 6 and 12-month plans are prepaid
None
Refunds
Fees are non-refundable except for medical disqualification, billing errors or where the law requires
No refund once a payment is processed; full refund of the first payment if found ineligible; 12-month weight-loss warranty on program fees

Read off each seller’s own pages. Fridays: October 30, 2026. Remedy Meds: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Fridays

5.8/10
  • No FDA warning letter on record
  • $600 a year less on compounded semaglutide injection
  • $480 a year less on compounded tirzepatide injection
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Remedy Meds does not price
  • Publishes no state list

The case for Remedy Meds

5.6/10

The record gives Remedy Meds no edge on this pair.

  • Open FDA warning letter, September 9, 2025
  • Names no compounding pharmacy

Scores

Fridays 5.8 · Remedy Meds 5.6 out of 10. Six weighted parts.

Value25%

3.4A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
2.5

Trust & Safety15%

5.5A
vs
B
2.0

Accessibility10%

5.0A
vs
B
9.8

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Fridays vs Remedy Meds: questions

Remedy Meds has an open FDA warning letter dated September 9, 2025. Fridays has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Fridays names four pharmacies. Remedy Meds names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Fridays, by $600 a year at standing rates. Fridays: $249 a month, about $2,988 a year. Remedy Meds: $299 a month, about $3,588 a year.
Fridays states you can cancel at any time; refunds: fees are non-refundable except for medical disqualification, billing errors or where the law requires. Remedy Meds states you can cancel at any time; refunds: no refund once a payment is processed; full refund of the first payment if found ineligible; 12-month weight-loss warranty on program fees.
Neither Fridays nor Remedy Meds pays us. Links to them earn nothing. Scores: Fridays 5.8, Remedy Meds 5.6.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks